Sridhara S, Gungor AB, Erol HK, Al-Obaidi M, et al. Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era. PLoS One 2023;18:e0279326.
PMID: 37115780